Top Section/Ad
Top Section/Ad
Most recent
Payment processor's shares dropped to new low on Thursday
Large capital increase led to high volatility in the stock
Tirlán sells €230m block in Glanbia to buy back bonds
More articles/Ad
More articles/Ad
More articles
-
Swiss biotechnology company Idorsia has opened the books on its Sfr575m ($629m) at-market rights issue to fund the commercialisation of insomnia drug daridorexant. -
Euronext is preparing for a €2.4bn equity raise after it agreed a deal with London Stock Exchange Group for the Borsa Italiana.
-
Korian, the French nursing home operator, has launched a €400m rights issue to buy Inicea, a French operator of psychiatry clinics.
-
Swiss biotechnology company Idorsia has begun marketing for a Sfr575m at-market rights offer to fund the commercialisation of its lead product candidate.
-
Philippine carrier Cebu Air is looking to tap the equity markets for $500m, in an attempt to position itself for a recovery from the impact of the Covid-19 pandemic.
-
Dufry, the Swiss operator of duty free retailers, has launched a Sfr700m ($766m) rights issue for M&A and corporate capital needs. The rights issue will allow two strategic investors, Advent Group and Chinese e-commerce firm Alibaba to take large stakes in the company.
